A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback